Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Recombinant African Swine Fever Virus mRNA-capping Enzyme, N-His

Cat. No.VG9C247

Product TypeVeterinary Antigens

Size

Product Overview

BioVenic's Recombinant African Swine Fever Virus mRNA-capping Enzyme, N-His is a recombinant protein expressed from E.coli. Its predicted molecular weight is 34. 8 kDa. The purity is>90% (SDS-PAGE).

Specifications

Type Recombinant Protein
Species Virus
Expression System E.coli
Purity >90% (SDS-PAGE)
Predicted Molecular Weight 34. 8 kDa
Physical State Lyophilized
Formulation The buffer before lyophilization is a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Target Information

African swine fever virus mRNA-capping enzyme is essential for the virus's replication and immune evasion. It ensures the stability and translation of viral mRNA by adding a methylguanosine cap to the 5' end, which is crucial for mRNA splicing, nuclear export, and protection from degradation. This enzyme helps the virus evade host immune responses by mimicking host mRNA, thereby preventing recognition by cellular pattern recognition receptors that trigger innate immunity. In veterinary medicine, understanding and targeting this enzyme could be key to developing therapeutics and vaccines against ASFV.

Protein African Swine Fever Virus mRNA-capping Enzyme
Protein Synonym VTF/CE
Gene ID 41902178
UniProt ID P32094

Shipping and Storage

This product is shipped with dry ice. Avoid repeated freezing and thawing. Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use.

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

User Note

  1. Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Reconstitute to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.Aliquote the reconstituted solution to minimise freeze-thaw cycles.

References

  1. Yu, L. et al.Structure-function analysis of the triphosphatase component of vaccinia virus mRNA capping enzyme. Journal of virology1997: 9837-43,71,12
Inquiry Basket